Table 3.
Cumulated top-ranked variables | Variables | AUC |
---|---|---|
2 | Tumor size and stage | 0.724 |
3 | Above variables plus ER | 0.771 |
4 | Above variables plus HT | 0.765 |
5 | Above variables plus LN metastasis | 0.790 |
6 | Above variables plus age | 0.806 |
7 | Above variables plus PR | 0.800 |
8 | Above variables plus MRE11 positive cells | 0.799 |
9 | Above variables plus BMI | 0.810 |
10 | Above variables plus HER2 | 0.821 |
11 | Above variables plus grade | 0.806 |
12 | Above variables plus CT | 0.799 |
13 | Above variables plus RT | 0.774 |
∗1Dataset and high/low risks of breast cancer recurrence were retrieved from our previous study [9]. ER: estrogen receptor; HT: hormone therapy; LN: lymph node; PR: progesterone receptor; BMI: body mass index; CT: chemotherapy; RT: radiotherapy.